Caribou Biosciences, Inc. (CRBU)
2.355
+0.10
(+4.67%)
USD |
NASDAQ |
Apr 22, 16:00
2.36
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences EPS Diluted (Quarterly) : -0.2802 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Illumina, Inc. | 2.169 |
| Pacific Biosciences of California, Inc. | -0.1337 |
| Beam Therapeutics, Inc. | 2.328 |
| EyePoint, Inc. | -0.8143 |
| Sarepta Therapeutics, Inc. | -3.934 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.49M |
| Revenue (Quarterly) | 3.941M |
| Total Expenses (Quarterly) | 30.43M |
| Enterprise Value | 105.32M |
| Gross Profit Margin (Quarterly) | 82.69% |
| Profit Margin (Quarterly) | -672.1% |
| Earnings Yield | -67.45% |
| Normalized Earnings Yield | -60.90 |